ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE
The Registrant (the "Company") supplements its October 17, 2003 press release regarding approval of its urine based HIV test in the Republic of Kenya. In the press release, the Company referred to a letter of intent dated September 16, 2003 from World Vision. The World Vision letter referred to a required confirmation and review certification of the Company's urine kit by the Kenyan Public Health Laboratory before World Vision would place an order for $1 million in the next quarter. The Company's HIV-1 Urine Assay Test Kit was submitted to the National AIDS Control Programme of the Ministry of Health and was found to be acceptable specifically for HIV test kits for use in Kenya. Subsequently, World Vision advised the Company that its prior announcement regarding the purchase of urine based test kits was incorrect and that World Vision had no intent to purchase such kits in the future as it generally relies upon government health agencies to perform HIV tests and does not purchase testing kits independently. The Company is continuing to investigate the matter and will not pursue the letter of intent.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c)
Exhibit 99.1 Company Press Release dated October 17, 2003
Exhibit 99.2 Letter of Intent from World Vision dated September
16, 2003
Exhibit 99.3 Letter of Approval from Kenyan Ministry of Health
National Public Health Laboratory dated October
17, 2003
Exhibit 99.4 Company Press Release dated November 3, 2003
|
Thread abonnieren
